Language: BG BG
← Back to results
Active (not recruiting) Not applicable NCT04877041

Exercise and Cardiac Stunning During HD

No applicable phase (e.g. observational)
Conditions: End-stage Kidney Disease Hemodialysis

Sponsor: University of Manitoba

trial.available_in: БГ
Overview
The purpose of this study is to determine the effect of a 12-week cycling during hemodialysis program on hemodialysis-induced myocardial stunning in adult individuals receiving hemodialysis.
Description
People with kidney failure receiving chronic hemodialysis (HD) suffer from post-HD treatment fatigue, poor functional status and high rates of cardiac failure and death. Previous work has shown that these outcomes are correlated with recurrent ischemic cardiac injury (myocardial stunning) that occurs during HD treatments. Myocardial stunning, identified by regional cardiac wall motion abnormalities (RWMA), is common during HD. Intradialytic cycling (during HD) decreases HD-induced stunning, and may improve adverse outcomes associated with stunning. We will use echocardiography (echo) to understand the effects of intradialytic aerobic exercise on myocardial stunning and HD-related symptoms.
Who can participate
Inclusion Criteria: * Adults greater than or equal to 18 years old (no upper age limit); who are greater than; 3 months after starting maintenance hemodialysis * No expected change in dialysis modality, elective surgery or relocation outside of study site during the intervention period (16 weeks) * Assessed to be safe and able to exercise by the hemodialysis unit nephrologist * Able to communicate in English and provide written informed consent * Must be dialyzing thrice weekly Exclusion Criteria: * Acute coronary syndrome in the past 3 months * Unstable arrhythmia * Shortness of breath at rest or with minimal activity (NYHA Class 4) * Symptomatic hypoglycemia (\>2x/week in week prior to enrolment) * Participating in clinical intradialytic cycling program in last 3 months (if a clinical program exists)
Locations 2
Australia (1)
University of South Australia
Adelaide , South Australia
Canada (1)
University of Calgary Cumming School of Medicine Department of Internal Medicine
Calgary , Alberta
Technical details
Status
Active (not recruiting)
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
01.03.2023
Completion date
01.03.2026
Registry ID
NCT04877041
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.